Changchun High‑Tech's Firsekibart Filing Accepted for Non‑Infectious Uveitis
CompanyDrug

Changchun High‑Tech’s Firsekibart Filing Accepted for Non‑Infectious Uveitis

Danaher Q4 Revenue Grows 3% to $24.6B on Biotech and Diagnostics Innovation
Company

Danaher Q4 Revenue Grows 3% to $24.6B on Biotech and Diagnostics Innovation

Distinct Healthcare IPO Hong Kong: Private Provider Seeks $36M HKEX Listing
CompanyDeals

Distinct Healthcare IPO Hong Kong: Private Provider Seeks $36M HKEX Listing

Merck Establishes Chongqing China Branch in Milestone Expansion
Company

Merck Establishes Chongqing China Branch in Milestone Expansion

Biogen's Litifilimab Secures FDA Breakthrough Therapy Designation for Lupus
CompanyDeals

Biogen’s Litifilimab Secures FDA Breakthrough Therapy Designation for Lupus

Seamless Therapeutics Partners with Eli Lilly on $1.12B Hearing Loss Recombinase Deal
CompanyDeals

Seamless Therapeutics Partners with Eli Lilly on $1.12B Hearing Loss Recombinase Deal

CompanyDrug

Sino Biopharm’s TQA3605 Meets Endpoint in Hepatitis B Phase II Trial

CompanyDrug

J&J Darzalex Faspro Gets FDA Nod for NDMM D-VRd Regimen

CompanyDrug

Roche CT-388 Obesity Drug Shows 22.5% Weight Loss in Phase II Trial

Policy / Regulatory

FDA Removes Suicide Warnings from GLP‑1 Drugs After Investigation Finds No Causal Link

Leqvio Gets NMPA Nod for Monotherapy in China Hypercholesterolemia
CompanyDrug

Leqvio Gets NMPA Nod for Monotherapy in China Hypercholesterolemia

Apeloa Partners with MindRank on AI Drug Development Platform
CompanyDeals

Apeloa Partners with MindRank on AI Drug Development Platform